Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
-
Clinical Trial Information
Trial Contact: Cox, Caitlin L; Ngo, George M.; Hernandez-Pagan, Gloryvee; Soto, William
Trial Phone: 321-841-1505 ; 3218439657 ; 321-841-3686 ; 321-843-1179
-
IRB No: W23.086.05
Protocol Abbrev: LeAAPS
Principal Investigator: Anthony J. Rongione, MD
Phase: Device: Risk not yet determined
Age Group: Adult
Secondary Protocol No: CP-2021-05
Treatment: LAA Exclusion
Therapies Involved: Procedural
ClinicalTrials.gov ID: NCT05478304
-
Objective
To demonstrate the effectiveness of LAA exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.
-
Key Eligibility
18 years of age or older, undergoing planned cardiac surgery, without documented clinical diagnosis of atrial fibrillation, who also present with documented risk factors for developing atrial fibrillation and ischemic stroke.
